Back

ResearchAndMarkets.com adds sapanisertib forecast report through 2034

Verifying
  • ResearchAndMarkets.com added a sapanisertib sales forecast and market-size analysis report.
  • 2020-2034 forecasts cover seven markets: the United States, six European countries and Japan.
  • Sensei Biotherapeutics dosed the first patient in PIKTOR’s Phase Ib/II study in May 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.